ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of December

December 27, 2013

Radiosensitizer Screen Concept OK’d, Acoustic Microscopy Delayed

March 2, 1990

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979

Treatment Division Outlines Future Program Areas

January 24, 1975

Uncertainty Lingers After NCI Meeting With Army; Activists Offer Advice

November 6, 1992

Combination Therapy Improves Survival For HIV+ Patients

February 24, 2006